Skip to content
The Nexus
DossierENTITY

Inceptive Nucleics

Coverage of Inceptive Nucleics in the Nexus archive.

Earliest in view: Jun 3 · 20:45 UTCMost recent: Jun 4 · 13:37 UTC
Co-mentioned in this coverage
Jakob Uszkoreitperson2RNA interferencetopic1mRNAtopic1antisense drugstopic1Congressorganization1DNA safeguardstopic1transformer architecturetopic1Alnylamorganization1RNAi therapeuticstopic1AI foundation modelstopic1Googleorganization1
Recent coverage
  • SCIENCEJun 4 · 13:37 UTCSTAT NEWS
    STAT+: AI titans push Congress for DNA safeguards

    Jakob Uszkoreit, co-creator of the transformer architecture behind ChatGPT, is leading Inceptive Nucleics to develop biological foundation models for RNA interference, mRNA, and antisense drugs. The article also mentions ongoing discussions in Congress about DNA safeguards, though the primary focus is on biotech advancements.

  • BUSINESSJun 3 · 20:45 UTCSTAT NEWS
    STAT+: Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeutics

    Alnylam partners with Inceptive Nucleics to develop AI foundation models for RNAi therapeutics. The three-year collaboration is worth up to $2 billion, with $30 million upfront in cash and equity. Jakob Uszkoreit, former Google researcher, co-founded Inceptive Nucleics after contributing to foundational AI research.

Inceptive Nucleics · Dossier · The Nexus